- Investing Ideas
- Global Pharmaceuticals & Biotech Undervalued based on future growth
Global Pharmaceuticals & Biotech Undervalued based on future growth
Results
40
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
40 companies
Grifols
Market Cap: €5.5b
Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.
GRF
€9.13
7D
1.6%
1Y
-25.3%
Organon
Market Cap: US$3.5b
Develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$13.49
7D
0%
1Y
39.9%
Hypera
Market Cap: R$14.8b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$20.98
7D
3.1%
1Y
-21.5%
Harmony Biosciences Holdings
Market Cap: US$2.0b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States.
HRMY
US$33.53
7D
-12.2%
1Y
-8.0%
ADMA Biologics
Market Cap: US$2.0b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$8.81
7D
-5.0%
1Y
-49.9%
Hugel
Market Cap: ₩2.6t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩239,500.00
7D
1.5%
1Y
-32.5%
ANI Pharmaceuticals
Market Cap: US$1.7b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$81.92
7D
-2.2%
1Y
20.4%
Bora Pharmaceuticals
Market Cap: NT$52.9b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$415.50
7D
-2.5%
1Y
-39.9%
Square Pharmaceuticals
Market Cap: ৳199.5b
Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳225.00
7D
1.8%
1Y
5.6%
Lotus Pharmaceutical
Market Cap: NT$52.0b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$198.00
7D
-2.9%
1Y
-11.2%
Pharma Mar
Market Cap: €1.3b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€76.00
7D
-7.5%
1Y
-7.3%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥8.0b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥14.75
7D
-13.9%
1Y
-8.4%
Luye Pharma Group
Market Cap: HK$8.9b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$2.22
7D
16.2%
1Y
-43.1%
Shanghai Haohai Biological Technology
Market Cap: HK$7.9b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$16.55
7D
4.0%
1Y
-43.6%
Strides Pharma Science
Market Cap: ₹96.7b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.
STAR
₹1,049.20
7D
-2.5%
1Y
17.1%
SSY Group
Market Cap: HK$7.3b
An investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.54
7D
10.4%
1Y
-18.3%
Shandong Wit Dyne HealthLtd
Market Cap: CN¥6.1b
Engages in the pharmaceutical business in China.
000915
CN¥26.09
7D
6.9%
1Y
-21.9%
Genomma Lab Internacional. de
Market Cap: Mex$14.6b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
LAB B
Mex$14.95
7D
-1.2%
1Y
-27.5%
China Shineway Pharmaceutical Group
Market Cap: HK$6.3b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.40
7D
11.6%
1Y
0.6%
Oscotec
Market Cap: ₩1.2t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩30,150.00
7D
-3.4%
1Y
-13.0%
Zevra Therapeutics
Market Cap: US$766.1m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$12.76
7D
-8.5%
1Y
0.8%
Omeros
Market Cap: US$750.5m
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.
OMER
US$9.22
7D
-10.2%
1Y
164.9%
Hunan Fangsheng Pharmaceutical
Market Cap: CN¥4.4b
Engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China.
603998
CN¥10.13
7D
10.3%
1Y
-4.7%
DongKook Pharmaceutical
Market Cap: ₩870.2b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩19,290.00
7D
5.3%
1Y
3.4%
Beximco Pharmaceuticals
Market Cap: ৳68.4b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally.
BXPHARMA
৳153.30
7D
-0.3%
1Y
57.7%
Renata
Market Cap: ৳54.6b
Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh.
RENATA
৳475.90
7D
3.3%
1Y
-3.7%
Blau Farmacêutica
Market Cap: R$2.3b
A pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.
BLAU3
R$9.68
7D
-6.5%
1Y
-3.2%
Abeona Therapeutics
Market Cap: US$415.5m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$7.02
7D
-1.4%
1Y
5.9%
Clinuvel Pharmaceuticals
Market Cap: AU$509.8m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$10.11
7D
-3.3%
1Y
-9.2%
Viva Biotech Holdings
Market Cap: HK$2.8b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.32
7D
10.0%
1Y
-17.0%
Medy-Tox
Market Cap: ₩466.7b
Operates as a biopharmaceutical company in South Korea.
A086900
₩71,600.00
7D
0.7%
1Y
-55.9%
Egyptian International Pharmaceutical Industries
Market Cap: ج.م15.0b
Manufactures and sells pharmaceutical ampoules in Egypt and internationally.
PHAR
ج.م88.97
7D
3.3%
1Y
67.9%
Jacobson Pharma
Market Cap: HK$2.1b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.06
7D
-1.9%
1Y
-36.1%
SIGA Technologies
Market Cap: US$245.3m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$3.56
7D
0.6%
1Y
-47.5%
Essex Bio-Technology
Market Cap: HK$1.6b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$2.84
7D
0%
1Y
-46.3%
Daihan PharmaceuticalLtd
Market Cap: ₩150.8b
Engages in the manufacture and sale of therapeutic drugs in South Korea.
A023910
₩25,650.00
7D
0.6%
1Y
-23.9%